Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing News e-Newsletter | Subscribe | Pharma Marketing Online Discussion Forum
Reports | Resources/Links | Glossary | Case Studies | Surveys | Pharma Marketing Blog
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy
| Also see Pharma Marketing News OpEd Pieces |
Proposal for a Drug Risk Advisory System
Posted: May 12, 2005Recently the FDA published guidelines for a Drug Watch program to provide emerging drug safety information to the public (see "FDA Drug Watch Site Guidelines).
Drug Risk Advisory System
Taking a page from the Homeland Security Advisory system, I propose a similar color-coded system for notifying the public about drug risks. You can see my color chart on the left.
This system is explained in my comments submitted to the FDA (Read more...).
You too can submit comments on the proposed Drug Watch program. Submit written comments on the draft guidance to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to www.fda.gov/dockets/ecomments. Refer to Docket No. 2005D-0062, DOCID:fr10my05-95.